237 related articles for article (PubMed ID: 17229915)
1. Unrestricted C3 activation occurs in Crry-deficient kidneys and rapidly leads to chronic renal failure.
Bao L; Wang Y; Chang A; Minto AW; Zhou J; Kang H; Haas M; Quigg RJ
J Am Soc Nephrol; 2007 Mar; 18(3):811-22. PubMed ID: 17229915
[TBL] [Abstract][Full Text] [Related]
2. Crry deficiency in complement sufficient mice: C3 consumption occurs without associated renal injury.
Ruseva MM; Hughes TR; Donev RM; Sivasankar B; Pickering MC; Wu X; Harris CL; Morgan BP
Mol Immunol; 2009 Feb; 46(5):803-11. PubMed ID: 18947875
[TBL] [Abstract][Full Text] [Related]
3. DAF/Crry double deficiency in mice exacerbates nephrotoxic serum-induced proteinuria despite markedly reduced systemic complement activity.
Miwa T; Zhou L; Tudoran R; Lambris JD; Madaio MP; Nangaku M; Molina H; Song WC
Mol Immunol; 2007 Jan; 44(1-3):139-46. PubMed ID: 16887189
[TBL] [Abstract][Full Text] [Related]
4. Mouse podocyte complement factor H: the functional analog to human complement receptor 1.
Alexander JJ; Wang Y; Chang A; Jacob A; Minto AW; Karmegam M; Haas M; Quigg RJ
J Am Soc Nephrol; 2007 Apr; 18(4):1157-66. PubMed ID: 17344423
[TBL] [Abstract][Full Text] [Related]
5. Mesangial cell complement receptor 1-related protein y limits complement-dependent neutrophil accumulation in immune complex glomerulonephritis.
Bao L; Wang Y; Chen P; Sarav M; Haas M; Minto AW; Petkova M; Quigg RJ
Immunology; 2009 Sep; 128(1 Suppl):e895-904. PubMed ID: 19740350
[TBL] [Abstract][Full Text] [Related]
6. Mouse Crry/p65 is a regulator of the alternative pathway of complement activation.
Foley S; Li B; Dehoff M; Molina H; Holers VM
Eur J Immunol; 1993 Jun; 23(6):1381-4. PubMed ID: 8500531
[TBL] [Abstract][Full Text] [Related]
7. Loss of CD11b exacerbates murine complement-mediated tubulointerstitial nephritis.
Chaves LD; Bao L; Wang Y; Chang A; Haas M; Quigg RJ
PLoS One; 2014; 9(3):e92051. PubMed ID: 24632830
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific deletion of Crry from mouse proximal tubular epithelial cells increases susceptibility to renal ischemia-reperfusion injury.
Miao J; Lesher AM; Miwa T; Sato S; Gullipalli D; Song WC
Kidney Int; 2014 Oct; 86(4):726-37. PubMed ID: 24850152
[TBL] [Abstract][Full Text] [Related]
9. Complement is activated in kidney by endotoxin but does not cause the ensuing acute renal failure.
Cunningham PN; Holers VM; Alexander JJ; Guthridge JM; Carroll MC; Quigg RJ
Kidney Int; 2000 Oct; 58(4):1580-7. PubMed ID: 11012892
[TBL] [Abstract][Full Text] [Related]
10. Local renal complement C3 induction by donor brain death is associated with reduced renal allograft function after transplantation.
Damman J; Nijboer WN; Schuurs TA; Leuvenink HG; Morariu AM; Tullius SG; van Goor H; Ploeg RJ; Seelen MA
Nephrol Dial Transplant; 2011 Jul; 26(7):2345-54. PubMed ID: 21127132
[TBL] [Abstract][Full Text] [Related]
11. Crry, a complement regulatory protein, modulates renal interstitial disease induced by proteinuria.
Hori Y; Yamada K; Hanafusa N; Okuda T; Okada N; Miyata T; Couser WG; Kurokawa K; Fujita T; Nangaku M
Kidney Int; 1999 Dec; 56(6):2096-106. PubMed ID: 10594785
[TBL] [Abstract][Full Text] [Related]
12. Distinct roles for C3a and C5a in complement-induced tubulointerstitial injury.
Bao L; Wang Y; Haas M; Quigg RJ
Kidney Int; 2011 Sep; 80(5):524-34. PubMed ID: 21677637
[TBL] [Abstract][Full Text] [Related]
13. Expression of a soluble complement inhibitor protects transgenic mice from antibody-induced acute renal failure.
Schiller B; Cunningham PN; Alexander JJ; Bao L; Holers VM; Quigg RJ
J Am Soc Nephrol; 2001 Jan; 12(1):71-79. PubMed ID: 11134252
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injury.
Leinhase I; Schmidt OI; Thurman JM; Hossini AM; Rozanski M; Taha ME; Scheffler A; John T; Smith WR; Holers VM; Stahel PF
Exp Neurol; 2006 Jun; 199(2):454-64. PubMed ID: 16545803
[TBL] [Abstract][Full Text] [Related]
15. The many effects of complement C3- and C5-binding proteins in renal injury.
Puri TS; Quigg RJ
Semin Nephrol; 2007 May; 27(3):321-37. PubMed ID: 17533009
[TBL] [Abstract][Full Text] [Related]
16. Complement factor H deficiency and posttransplantation glomerulonephritis with isolated C3 deposits.
Boyer O; Noël LH; Balzamo E; Guest G; Biebuyck N; Charbit M; Salomon R; Frémeaux-Bacchi V; Niaudet P
Am J Kidney Dis; 2008 Apr; 51(4):671-7. PubMed ID: 18371543
[TBL] [Abstract][Full Text] [Related]
17. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H.
Pickering MC; Cook HT; Warren J; Bygrave AE; Moss J; Walport MJ; Botto M
Nat Genet; 2002 Aug; 31(4):424-8. PubMed ID: 12091909
[TBL] [Abstract][Full Text] [Related]
18. Complement-mediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF. Decay-accelerating factor.
Molina H; Miwa T; Zhou L; Hilliard B; Mastellos D; Maldonado MA; Lambris JD; Song WC
Blood; 2002 Dec; 100(13):4544-9. PubMed ID: 12393518
[TBL] [Abstract][Full Text] [Related]
19. Distinct roles for the complement regulators factor H and Crry in protection of the kidney from injury.
Laskowski J; Renner B; Le Quintrec M; Panzer S; Hannan JP; Ljubanovic D; Ruseva MM; Borza DB; Antonioli AH; Pickering MC; Holers VM; Thurman JM
Kidney Int; 2016 Jul; 90(1):109-22. PubMed ID: 27165610
[TBL] [Abstract][Full Text] [Related]
20. Generation of C5a in the absence of C3: a new complement activation pathway.
Huber-Lang M; Sarma JV; Zetoune FS; Rittirsch D; Neff TA; McGuire SR; Lambris JD; Warner RL; Flierl MA; Hoesel LM; Gebhard F; Younger JG; Drouin SM; Wetsel RA; Ward PA
Nat Med; 2006 Jun; 12(6):682-7. PubMed ID: 16715088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
